Premier Research gets bid approach

British pharma Premier Research has some ultra-ambitious managers--they're bidding for a takeover. The company announced that a group of executives has expressed interest in mounting a buyout, making clear it's skeptical that an actual offer will be forthcoming. Just in case, Premier's board has formed an independent committee to consider the bid, if one is eventually made. The company's shares were up 10 percent in early trading.

- read the AFX report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

North Korean hackers were accused of posing as corporate recruiters in a scheme to breach AstraZeneca's computer systems and steal COVID-19 research.

The FDA has delayed its review of Revance's frown-line injection candidate after it failed to inspect a key manufacturing facility on time.

McKinsey & Company helped guide Purdue's strategy for years and pitched the idea of rebates to distributors for overdoses, according to the NYT.